MedTrace Logo

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

NCT02469207 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-07-14

No results posted yet for this study

Summary

This study aims to use tissue from deceased organ donors to investigate organ physiology, developmental biology, as well as the development of future regenerative cellular therapies. It will investigate function and immune response to stem cells as well as their generation from adult cells and generation of induced pluripotent stem cells (iPSCs).

Conditions

Interventions

OTHER

Removal of tissue post-mortem

Sponsors & Collaborators

  • University of Cambridge

    collaborator OTHER

  • Cambridge Stem Cell Institute, Cambridge

    collaborator UNKNOWN

  • Anne McLarent Laboratory of Regenerative Medicine, Cambridge

    collaborator UNKNOWN

  • The Gurdon Institute, Cambridge

    collaborator UNKNOWN

  • Sanger Institure, Cambridge

    collaborator UNKNOWN

  • Institute of Metabolic Science, Cambridge

    collaborator UNKNOWN

  • MRC Mitochondrial Biology Unit, Cambridge

    collaborator UNKNOWN

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Kourosh Saeb-Parsy, PhD, FRCS · Cambridge Univeristy Hospitals

Eligibility

Min Age
16 Years
Max Age
92 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02469207 on ClinicalTrials.gov